"Ten
Ideas that Have Already Decided the Future" Peter Schwartz , Cofounder and Chairman,
Global Business Network, and author, The Long Boom: The Coming
Age of Prosperity.
International A-E
10:30 AM
Coffee Break
Apex Technology Arena
Opportunity to make appointments with NIST and ATP staff as
well as selected speakers
12:00 Noon
CHRISTOPHER
REEVE, Keynote Speaker
Actor and Biomedical Research Advocate
International A-E
1:00 PM
Lunch
Apex Technology Arena
Opportunity to make appointments with NIST and ATP staff as
well as selected speakers
2:00 PM
FRONTIER FORUMS
SELECT FORUM 1 OR FORUM 2 AND INDICATE YOUR
SELECTION ON THE REGISTRATION FORM
Forum 1: "Manufacturing With 2020
Intelligence"
International D-E Roger W. Cope, Vice President Business
Development, Lamb Technicon, Machining Systems Charles L. Bailey, Vice President,
Chemicals and Life Sciences Operations and Maintenance, Fluor
Global Services
Manufacturing represents an opportunity to create significant
national wealth and added value. How that will be done in
the future, and how that will differ from the present is anyone's
guess. This Frontier Forum will present the views and opinions
on the future of manufacturing and processing in a variety
of industrial sectors.
What will manufacturing facilities look like?
What new technologies will need to be developed?
What will the operating requirements be?
Where can greater intelligence and knowledge be built in?
These are just a few of the questions that will be addressed.
The presentations will lay the foundation for future technology-based
discussions on development needs and opportunities, leading
to the beginning of long term planning for R&D collaborations
and ventures.
Forum 2: "Virtual Voyage Through
Medicine"
International A-C Dr. Michael J. Ackerman, Visible
Human Project: From Data to Knowledge
National Library of Medicine Dr. Richard M. Satava, Yale University
School of Medicine Dr. Yulun Wang, Founder/CTO, Computer
Motion
Virtual Reality (VR) has found its place on the frontiers
of medicine where it is transforming all aspects of healthcare.
VR is revolutionizing healthcare delivery, training, research
and education. It is breaking through the barriers of distance,
enabling quality care in remote geographical areas. By providing
new, effective methods for medical education and training,
virtual reality will enable surgeons to practice a planned
procedure before the patient enters the operating room. Once
in the operating room, the surgeon can be guided using visualization
technologies, with robots on hand to assist with some of the
most difficult procedures. This Frontier Forum will present
information from leading experts in virtual reality in medicine.
Where is virtual reality pushing the frontiers of medicine?
What is beyond this virtual voyage?
3:30 PM
Coffee Break
Apex Technology Arena
Opportunity to make appointments with NIST and ATP staff as
well as selected speakers (1:00 PM to 5:00 PM)
4:00 PM
FRONTIER FORUMS
SELECT FORUM 3 OR FORUM 4 AND INDICATE YOUR
SELECTION ON THE REGISTRATION FORM
Forum 3: "The Pathway to Virtual
Research Communities"
International D-E Dr. H. Mario Geysen, GlaxoSmithKline Dr. F. Raymond Salemme, 3-Dimensional
Pharmaceuticals, Inc. Dr. Ian Maxwell, Avantium Technologies
B.V., Netherlands
The concept of Virtual Research Communities is one of geographically
dispersed research centers utilizing intelligent research
tools that are connected to each other via high-bandwidth
networks. This Frontier Forum will describe potential paths
forward for attaining the convergence of hardware and software
technologies needed to develop the next generation technologies
for the high throughput screening and discovery of tomorrow's
advanced materials.
Forum 4: "Replication of Nanodevices"
International A-C Ralph Merkle, Zyvex, Richardson,
TX J. Storrs Hall, Institute for Molecular
Manufacturing, Palo Alto, CA
Many examples of biological replication exist in nature. The
replication of biological structures usually requires an increasing
array of tools and building blocks as the complexity of the
structure increases. Manufacturing products with nanometer-scale
features also requires elaborate tools to organize and manipulate
atoms and molecules. At present, this process is painstakingly
slow and not readily scaleable. However, some applications
may be satisfied through biologically-inspired approaches
where systems spontaneously self-assemble and replicate with
nanometer-scale precision. This strategy may represent a truly
low-cost manufacturing approach for nano-devices. This session
will cover molecular replicating systems, including replications
of more complex structures on the nanometer scale and exponential
assembly into larger devices at the micron scale.
6:00 PM
Cash Bar/Reception
Apex Technology Arena
TUESDAY,
JUNE 5
7:00 AM
Continental Breakfast
Apex Technology Arena
8:00 AM
"Building Value Roadmaps for Frontier Technology with
Real Options"
International A-E Dr. F. Peter Boer, President and CEO,
Tiger Scientific, Inc., and Adjunct Professor, Chemical Engineering
and Management, Yale University
8:45 AM
VENTURE CAPITAL FORUM
International A-E
Presentation:
Linda Powers, Managing Director,
Toucan Capital
Panel:
Wei-wu He, Cofounder, General
Partner, Emerging Technology Partners, LLC
William Schneider, General Partner,
Emerging Technology Partners, LLC
Michael Sheridan, Managing Partner,
Mohr, Davidow Ventures
Ginger Ehn Lew, CEO, Telecommunication
Development Fund
Mike Joseph, Managing Director,
Optical Capital Group
Dr. Katya Flakshahi, Partner,
New Enterprise Associates
Questions to Panel
The goal of this Forum is to provide you with information
on how Venture Capital firms choose the Frontier Technologies
that they decide to fund out of an expanding universe of emerging
technologies. This goal will be achieved by looking at some
historical perspectives and the wisdom of recent selections
in different areas of technology. For example, did the Venture
Capital community foresee the rise of the Internet and the
rocky road of the dot-coms? How do such events affect their
future investments? These are important issues facing startup
companies when developing and commercializing their path-breaking
technologies.
10:30 AM
Coffee Break
Apex Technology Arena
Opportunity to make appointments with NIST and ATP staff as
well as selected speakers per appointments.
11:00 AM
FRONTIER FORUMS
SELECT FORUM 5 OR FORUM 6 AND INDICATE YOUR
SELECTION ON THE REGISTRATION FORM
Forum 5: "Connectelligence: The
Convergence of People, Machines and Their Environment"
International D-E Brock Hinzman, Technology Navigator
SRI Consulting Business Intelligence, Menlo Park, CA Dr. Charles Shanley, Vice President
and Director
Technology and Special Government Programs, Motorola, Schaumburg,
IL
How might healthcare, transportation, commerce, and even running
a household be transformed, if at our fingertips, we could
obtain and use information in real-time to exert control over
our environment? Across our everyday lives, pervasive, ultra-low-cost
and compact connected intelligence is increasingly integrating
people, machines, and our environment into one. "Connectelligence"
represents this convergence of smart electronic devices and
materials, ultra-low cost electronics and photonics, embedded
intelligence, ubiquitous computing, advanced networking, and
knowledge-based system technologies. This Frontier Session
will explore some of the opportunities likely to unfold as
these technological enablers allow citizens to more effectively
and enjoyably interface with the world around them.
Forum 6: "Diagnostics Imaging
in the New Millennium"
International A-C Dr. Dan Silverman, MD, PhD, Associate
Professor, Nuclear Medicine, Pharmacology and Structural Biology
University of California-Los Angeles Dr. Nancy Albirtton, University
of California-Irvine
In this Frontier Session, the presenters will discuss the
areas of cutting-edge science and technology related to interactions
of photons with tissues in diagnostic imaging. Dr. Silverman
will describe the role of non-invasive imaging of neuro-degeneration
using a specific and sensitive radioactive tracers and positron
emission tomography (PET). While mutations can be diagnosed
using the tools of DNA diagnostics, micro arrays and biopsied
tissues or blood, the sites of disease in a patient should
be located, so that diseased tissue can be ablated using laser
technology or removed surgically at an early stage. With PET
imaging, the effect of drugs and gene therapy on the diseased
organs and tissues can be followed by sequential imaging techniques.
By combining the latest advances in genomics, proteomics and
functional imaging, diagnosis may become possible at a ultra
early stage, thus leading to reductions in morbidity and mortality
rates while improving the quality of life in a cost-effective
manner.
12:30 PM
Lunch
Apex Technology Arena
Opportunity to make appointments with NIST and ATP staff as
well as selected speakers per appoint until 4:00 PM
1:30 PM
FRONTIER FORUMS
SELECT FORUM 7 OR FORUM 8 AND INDICATE YOUR
SELECTION ON THE REGISTRATION FORM
Forum 7: "The Challenge of Molecular
Electronics: Focusing Nanotechnology on the Future Computer"
International D-E Christopher B. Murray, Manager,
Nanoscale Materials and Devices
IBM, T.J. Watson Research Center, Yorktown Heights, NY Dr. Paul Weiss, Professor of Chemistry,
The Pennsylvania State University, University Park, PA
Recent advances in the field of molecular-scale electronics
have raised expectations that this technology will one day
usher in a world of circuits only a few atoms wide, providing
the building blocks for ultra small, ultra dense, electronic
computer logic. Such revolutionary advances would radically
change the future of computing. What breakthroughs and consequent
spinoffs might we expect along the way? This Frontier session
will explore recent notable achievements that show the promise
of molecular scale electronics. Anticipating a stream of new
advances, such as molecular wires, molecular switches and
molecular sensors, particular attention will be placed on
the enabling, spillover possibilities for this rapidly moving
field.
Dr. William A. Haseltine, CEO,
Human Genome Sciences, Inc. Dr. Joseph Gold, Geron Corporation,
Genetic Engineering/Pluripotent Stem Cell Project
This Frontier Forum will feature two speakers and cover the
following topics:
"Tissue Regeneration", will outline
four developmental phases in the growth of regenerative
medicine, a term Dr. Haseltine coined to describe new ways
of using the body's own genes, proteins, antibodies, and
cells to regenerate injured, worn, and damaged tissues and
organs. Such innovations as replacement organs created in
the laboratory using a patient's own cells are foreseeable
in a matter of years. These and other developments are expected
to significantly extend the human life span.
"Human Embryonic Stem Cells: Applications for
Drug Discovery and Regenerative Medicine", will
focus on the latest advances of genetic modification into
Human Embryonic Stem Cells that facilitate their use for
both in vitro studies and in clinical applications. Dr.
Gold will also outline the usage of micro array technology
to identify genes that may play important roles in the creation
and maintenance of the pluripotent state. This information
may be of use in devising a method to "reprogram" a somatic
cell from a patient to form a stem cell whose differentiated
progeny could be used to make fully compatible tissues for
transplantation.
3:00 PM
Coffee Break
and Networking
Apex Technology Arena
Small group meetings scheduled with NIST, ATP staff,
and selected speakers
Individual meetings with speakers, project managers,
and NIST Laboratory Scientists
Post displays describing the Intramural programs in which
ATP is involved with the NIST Laboratories (Carroll, Menchen,
E.A. Poe, Pratt & Hopkins rooms).
"Ten
Ideas that Have Already Decided the Future"
"Building Value Roadmaps for Frontier Technology with
Real Options"